01—Abstract
Summary
Summary of the 10-K filed August 4, 2026. Cited figures are marked; the original filing is the authoritative source.
Procter & Gamble's (PG) 10-K filing for the fiscal year ended June 30, 2026, indicates a company navigating a complex global economic landscape while maintaining strong operational performance.
Net sales grew 3% to $87.0 billiona, driven by pricing and favorable foreign exchange, though organic sales saw a modest 1% increase, with mixed performance across segments. Beauty and Health Care segments showed resilience, while Baby, Feminine & Family Care experienced a slight decline in organic sales. The company continues to focus on productivity improvements and portfolio streamlining, evidenced by a significant restructuring plan aimed at reducing overhead personnel and optimizing operations, which incurred substantial charges in fiscal 2026.
Financially, P&G demonstrated robust cash flow generation, with operating cash flow up 10% to $19.6 billionb, leading to an adjusted free cash flow of $15.8 billion and an impressive 100% adjusted free cash flow productivity. The company also highlighted its commitment to shareholder returns through consistent dividend payments and a completed $5 billion share repurchase program in fiscal year 2026.
Despite facing headwinds from cost fluctuations, geopolitical uncertainties, and evolving consumer habits, P&G's strategic focus on brand superiority, innovation, and productivity positions it to continue delivering shareholder value. The announced acquisition of Thorne for $3.8 billionc signals an intent to further strengthen its position in the wellness sector.
02—Key points
Key Highlights
- Net sales increased by 3% to $87.0 billion, with Beauty and Health Care segments showing strong growth.
- Organic sales grew by 1%, indicating a challenging but stable underlying demand across most categories.
- The company generated $19.6 billion in operating cash flow and $15.8 billion in adjusted free cash flow, showcasing strong cash generation.
- A significant restructuring plan targeting 7,000 overhead personnel by FY2027 was initiated, with over half of the estimated costs incurred in FY2026.
- P&G completed a $5 billion share repurchase program and maintained its commitment to returning capital to shareholders.
- The company announced an agreement to acquire Thorne for $3.8 billion, expanding its presence in the wellness and supplement market.
- The Gillette indefinite-lived intangible asset's fair value still exceeds its carrying value, although it remains susceptible to impairment risks.
03—Questions
Frequently Asked Questions
What is P&G's overall financial performance for fiscal year 2026?
For the fiscal year ended June 30, 2026, P&G reported a 3% increase in net sales to $87.0 billion. While operating income saw a slight decrease, net earnings and diluted EPS both saw modest increases. The company demonstrated strong cash flow generation, with operating cash flow up 10% and adjusted free cash flow at $15.8 billion.
How is P&G managing costs and improving efficiency?
P&G is actively pursuing productivity improvements and cost savings through a significant restructuring plan announced in June 2025. This plan includes reducing up to 7,000 non-manufacturing overhead personnel by the end of fiscal year 2027 and optimizing its portfolio and organization. The company incurred over half of the estimated $1.5 to $2.0 billion in before-tax restructuring costs in fiscal year 2026.
What is the outlook for P&G's key business segments?
The Beauty segment experienced high single-digit net sales growth, and Health Care saw mid-single-digit growth. Grooming also showed mid-single-digit growth, while Fabric & Home Care and Baby, Feminine & Family Care had low single-digit growth. Organic sales trends were mixed, with Beauty and Health Care showing positive growth, while Baby, Feminine & Family Care saw a slight decline.
What is the company's strategy for growth and shareholder returns?
P&G's strategy focuses on delivering balanced top- and bottom-line growth through a portfolio of daily-use products where performance drives brand choice, aiming for superiority across five key vectors: product performance, packaging, brand communication, retail execution, and value. The company is committed to shareholder returns through consistent dividend payments and share repurchases. The recent acquisition of Thorne is expected to further enhance its strategic positioning in the wellness sector.
04—Continue